Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-27

Clinical Trial Update: Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and efficacy of azelaic acid 15% foam for papulopustular rosacea; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic Acid Foam 15% (azelaic acid)

Snippet

Sponsor: LEO Pharma | Conditions: Papulopustular Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2015-01-27